Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

The health and productivity cost burden of the "top 10" physical and mental health conditions affecting six large U.S. employers in 1999.

Goetzel RZ, Hawkins K, Ozminkowski RJ, Wang S.

J Occup Environ Med. 2003 Jan;45(1):5-14.

PMID:
12553174
2.

Health care use and at-work productivity among employees with mental disorders.

Berndt ER, Bailit HL, Keller MB, Verner JC, Finkelstein SN.

Health Aff (Millwood). 2000 Jul-Aug;19(4):244-56.

3.

Health and disability costs of depressive illness in a major U.S. corporation.

Druss BG, Rosenheck RA, Sledge WH.

Am J Psychiatry. 2000 Aug;157(8):1274-8.

PMID:
10910790
4.

Health, absence, disability, and presenteeism cost estimates of certain physical and mental health conditions affecting U.S. employers.

Goetzel RZ, Long SR, Ozminkowski RJ, Hawkins K, Wang S, Lynch W.

J Occup Environ Med. 2004 Apr;46(4):398-412.

PMID:
15076658
5.

Comparing the effects on work performance of mental and physical disorders.

de Graaf R, Tuithof M, van Dorsselaer S, ten Have M.

Soc Psychiatry Psychiatr Epidemiol. 2012 Nov;47(11):1873-83. doi: 10.1007/s00127-012-0496-7. Epub 2012 Mar 21.

PMID:
22434047
6.

The impact of rheumatoid arthritis on medical expenditures, absenteeism, and short-term disability benefits.

Ozminkowski RJ, Burton WN, Goetzel RZ, Maclean R, Wang S.

J Occup Environ Med. 2006 Feb;48(2):135-48.

PMID:
16474262
7.

Absenteeism and Employer Costs Associated With Chronic Diseases and Health Risk Factors in the US Workforce.

Asay GR, Roy K, Lang JE, Payne RL, Howard DH.

Prev Chronic Dis. 2016 Oct 6;13:E141. doi: 10.5888/pcd13.150503.

8.

The economic impact of bipolar disorder in an employed population from an employer perspective.

Gardner HH, Kleinman NL, Brook RA, Rajagopalan K, Brizee TJ, Smeeding JE.

J Clin Psychiatry. 2006 Aug;67(8):1209-18.

PMID:
16965198
9.

How much does quality mental health care profit employers?

Langlieb AM, Kahn JP.

J Occup Environ Med. 2005 Nov;47(11):1099-109. Review.

PMID:
16282870
10.

The cost of disability and medically related absenteeism among employees with multiple sclerosis in the US.

Ivanova JI, Birnbaum HG, Samuels S, Davis M, Phillips AL, Meletiche D.

Pharmacoeconomics. 2009;27(8):681-91. doi: 10.2165/11314700-000000000-00000.

PMID:
19712010
11.

Total costs of IBS: employer and managed care perspective.

Cash B, Sullivan S, Barghout V.

Am J Manag Care. 2005 Apr;11(1 Suppl):S7-16.

12.

Pharmaceuticals and worker productivity loss: a critical review of the literature.

Burton WN, Morrison A, Wertheimer AI.

J Occup Environ Med. 2003 Jun;45(6):610-21. Review.

PMID:
12802214
13.

The cost of depression in the workplace.

Conti DJ, Burton WN.

Behav Healthc Tomorrow. 1995 Jul-Aug;4(4):25-7.

PMID:
10172403
14.

Examining the comparative incidence and costs of physical and mental health-related disabilities in an employed population.

Dewa CS, Chau N, Dermer S.

J Occup Environ Med. 2010 Jul;52(7):758-62. doi: 10.1097/JOM.0b013e3181e8cfb5.

PMID:
20595909
15.

Using the interaction of mental health symptoms and treatment status to estimate lost employee productivity.

Hilton MF, Scuffham PA, Vecchio N, Whiteford HA.

Aust N Z J Psychiatry. 2010 Feb;44(2):151-61. doi: 10.3109/00048670903393605.

PMID:
20113304
16.

The association between employee obesity and employer costs: evidence from a panel of U.S. employers.

Van Nuys K, Globe D, Ng-Mak D, Cheung H, Sullivan J, Goldman D.

Am J Health Promot. 2014 May-Jun;28(5):277-85. doi: 10.4278/ajhp.120905-QUAN-428.

PMID:
24779722
17.

How to present the business case for healthcare quality to employers.

Nicholson S, Pauly MV, Polsky D, Baase CM, Billotti GM, Ozminkowski RJ, Berger ML, Sharda CE.

Appl Health Econ Health Policy. 2005;4(4):209-18.

PMID:
16466272
18.

Days Out of Role Due to Mental and Physical Conditions: Results from the Singapore Mental Health Study.

Abdin E, Ong C, Chong SA, Vaingankar JA, Subramaniam M.

PLoS One. 2016 Feb 3;11(2):e0148248. doi: 10.1371/journal.pone.0148248. eCollection 2016.

19.

Cost of disorders of the brain in Europe 2010.

Gustavsson A, Svensson M, Jacobi F, Allgulander C, Alonso J, Beghi E, Dodel R, Ekman M, Faravelli C, Fratiglioni L, Gannon B, Jones DH, Jennum P, Jordanova A, Jönsson L, Karampampa K, Knapp M, Kobelt G, Kurth T, Lieb R, Linde M, Ljungcrantz C, Maercker A, Melin B, Moscarelli M, Musayev A, Norwood F, Preisig M, Pugliatti M, Rehm J, Salvador-Carulla L, Schlehofer B, Simon R, Steinhausen HC, Stovner LJ, Vallat JM, Van den Bergh P, van Os J, Vos P, Xu W, Wittchen HU, Jönsson B, Olesen J; CDBE2010Study Group.

Eur Neuropsychopharmacol. 2011 Oct;21(10):718-79. doi: 10.1016/j.euroneuro.2011.08.008. Epub 2011 Sep 15. Erratum in: Eur Neuropsychopharmacol. 2012 Mar;22(3):237-8. den Bergh, Peter Van [corrected to Van den Bergh, Peter].

PMID:
21924589
20.

Impairment in work productivity and health-related quality of life in patients with IBS.

Dean BB, Aguilar D, Barghout V, Kahler KH, Frech F, Groves D, Ofman JJ.

Am J Manag Care. 2005 Apr;11(1 Suppl):S17-26.

Supplemental Content

Support Center